Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

Objective Biomarkers and FDA-Cleared Tools While existing tools represent decades of clinical and research development, they ...

Protein biomarkers are transforming neurodegenerative disease research—offering new ways to guide detection, monitoring, and understanding conditions such as Alzheimer’s and Parkinson’s. Yet turning ...

With a NOK 40 million (approx. €3.5 million) grant, Professor Srdjan Djurovic at the University of Oslo aims to identify early blood-based biomarkers that can predict who is at increased risk of ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon make it possible to more precisely match patients with their optimal therapy.

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers insights to how these can be overcome. Biomarker exploration has been a ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer.

VIJAYAWADA: For the first time, biomarker-based urine testing has been introduced in Uddanam to identify early signs of ...

As multicancer early detection research scales, generating sensitive and reproducible biomarker data across large studies remains a critical challenge. While advances in genomic and proteomic tools ...